Clinical TrialsSearch results
Number of results: 205
Other
- Multicenter diagnostic study for IgG4+MOLPS, Castleman's disease, and other polyclonal hypergammopathies
- IgG4+MOLPS, Castleman's disease, other polyclonal hypergammopathies, male Sjogen's syndrome
- Kanazawa Medical University
- 2009-08-10
Other
- Efficacy and Safty of Long Acting Beraprost (TRK-100STP) for Lumbar Spinal Canal Stenosis with Intermittent Claudication :A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial
- Acquired degenerative lumbar spinal canal stenosis
- KAKEN PHARMACEUTICAL CO., LTD.
- 2009-03-30
Other
- A multicenter study on early prediction of antipsychotic response in patients with schizophrenia
- schizophrenia
- Juntendo University School of Medicine
- 2009-06-01
Other
- Compliance study Medication Event Monitoring System-Utilizing Survey on Bisphosphonate Compliance in Osteoporotic Patients in Japan
- Osteoporotic
- JOCC [Japan Osteoporosis Central-committee for Compliance study]
- 2007-06-30
Other
- Clinical study of Landiolol hydrochloride in the treatment of postoperative atrial fibrillation/atrial flutter after cardiovascular surgery
- tachyarrhythmia
- JL-Knight Study Group
- 2007-12-27
Other
- RCC-SNPs Ensuring-study for Leading Eligibility of patients in Cytokine Therapy
- Renal cell carcinoma
- JISG-KC
- 2007-06-04
Other
- The Japanese Trial to Assess Optimal Systolic Blood Pressure in Elderly Hypertensive Patients (JATOS)
- Essential hypertension
- JATOS Study Group
- 2008-02-15
Other
- JPLT2 protocol (CITA and ITEC regimen)for the pediatric liver tumor in Japan
- hepatoblastoma hepatocellular carcinoma
- Japanese Study Group for Pediatric Liver Tumors
- 2008-04-09
Other
- Multi-Center Phase II Study on Efficacy of High-Slip Skin Care Pad for Hand-Foot Skin Reaction Caused by Sorafenib in Patients with Renal Cell Carcinoma
- Renal cell carcinoma
- Japanese Society of Renal Cancer (JSRC)
- 2009-05-29
Other
- Clinical study for the first relapsed ALL in children. JPLSG ALL-R08-II: Multicenter phase II clinical trial for children with non-T-ALL in intermediate risk group stratified by the minimal residual disease (MRD).
- first relapsed acute lymphoblastic leukemia in children
- Japanese Peditric Leukemia/Lymphoma Study Group(JPLSG)
- 2009-06-01